These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30075130)

  • 1. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.
    Li L; Tian E; Chen X; Chao J; Klein J; Qu Q; Sun G; Sun G; Huang Y; Warden CD; Ye P; Feng L; Li X; Cui Q; Sultan A; Douvaras P; Fossati V; Sanjana NE; Riggs AD; Shi Y
    Cell Stem Cell; 2018 Aug; 23(2):239-251.e6. PubMed ID: 30075130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.
    Kondo T; Funayama M; Miyake M; Tsukita K; Era T; Osaka H; Ayaki T; Takahashi R; Inoue H
    Acta Neuropathol Commun; 2016 Jul; 4(1):69. PubMed ID: 27402089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
    Battaglia RA; Beltran AS; Delic S; Dumitru R; Robinson JA; Kabiraj P; Herring LE; Madden VJ; Ravinder N; Willems E; Newman RA; Quinlan RA; Goldman JE; Perng MD; Inagaki M; Snider NT
    Elife; 2019 Nov; 8():. PubMed ID: 31682229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes.
    Jones JR; Kong L; Hanna MG; Hoffman B; Krencik R; Bradley R; Hagemann T; Choi J; Doers M; Dubovis M; Sherafat MA; Bhattacharyya A; Kendziorski C; Audhya A; Messing A; Zhang SC
    Cell Rep; 2018 Oct; 25(4):947-958.e4. PubMed ID: 30355500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
    Tian R; Gregor M; Wiche G; Goldman JE
    Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein is pathologically modified in Alexander disease.
    Lin NH; Jian WS; Snider N; Perng MD
    J Biol Chem; 2024 Jul; 300(7):107402. PubMed ID: 38782207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease.
    Hagemann TL; Coyne S; Levin A; Wang L; Feany MB; Messing A
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
    Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
    Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
    Hagemann TL; Connor JX; Messing A
    J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.
    Moody LR; Barrett-Wilt GA; Sussman MR; Messing A
    J Biol Chem; 2017 Apr; 292(14):5814-5824. PubMed ID: 28223355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
    Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
    APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis.
    Heaven MR; Herren AW; Flint DL; Pacheco NL; Li J; Tang A; Khan F; Goldman JE; Phinney BS; Olsen ML
    Mol Cell Proteomics; 2022 Jan; 21(1):100180. PubMed ID: 34808356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant astrocyte Ca
    Saito K; Shigetomi E; Yasuda R; Sato R; Nakano M; Tashiro K; Tanaka KF; Ikenaka K; Mikoshiba K; Mizuta I; Yoshida T; Nakagawa M; Mizuno T; Koizumi S
    Glia; 2018 May; 66(5):1053-1067. PubMed ID: 29383757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
    Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
    BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-Cell-Derived Astrocytes Divulge Secrets of Mutant GFAP.
    Sofroniew MV
    Cell Stem Cell; 2018 Nov; 23(5):630-631. PubMed ID: 30388417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.
    Yoshida T; Nakagawa M
    Neuropathology; 2012 Aug; 32(4):440-6. PubMed ID: 22118268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
    Sosunov AA; McKhann GM; Goldman JE
    Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
    Hagemann TL; Boelens WC; Wawrousek EF; Messing A
    Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.
    Tian R; Wu X; Hagemann TL; Sosunov AA; Messing A; McKhann GM; Goldman JE
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):335-45. PubMed ID: 20448479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model.
    Saito K; Shigetomi E; Shinozaki Y; Kobayashi K; Parajuli B; Kubota Y; Sakai K; Miyakawa M; Horiuchi H; Nabekura J; Koizumi S
    Brain; 2024 Feb; 147(2):698-716. PubMed ID: 37955589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.